Ketogenic diet and letrozole to inhibit PI3K signaling in ER plus breast cancer

被引：0
|
作者：
Rexer, Brent
Abramson, Vandana
Nunnery, Sara
Reid, Sonya
Kennedy, Laura
Sanders, Melinda
Bennett, Jessica
Gonzalez-Ericsson, Paula
Sanchez, Violeta
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-02-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-02-03
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combinatorial targeting of PI3K and MAPK signaling pathways using microRNAs to inhibit cell proliferation and invasion in breast cancer
    Sahin, O.
    Mutlu, M.
    Saatci, O.
    Ansari, S.
    Raza, U.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S174 - S174
  • [22] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [23] Targeting the PI3K signaling pathway in cancer
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    Cantley, Lewis C.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (01) : 87 - 90
  • [24] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [25] Targeting PI3K/mTOR Signaling in Cancer
    Emerling, Brooke M.
    Akcakanat, Argun
    CANCER RESEARCH, 2011, 71 (24) : 7351 - 7359
  • [26] Crosstalk between ER and PI3K signaling pathways in human luminal type breast cancer and its therapeutic implications
    Fu, Xiaoyong
    Nanda, Sarmistha
    Gillihan, Ryan M.
    Shea, Martin
    Creighton, Chad J.
    Hilsenbeck, Susan G.
    Lee, Adrian V.
    Schiff, Rachel
    Osborne, Kent C.
    CANCER RESEARCH, 2011, 71
  • [27] Incidence of oncogenes in PI3K/AKT and MAPK signaling pathways in breast cancer
    Cejalvo, J. M.
    Perez Fidalgo, J. A.
    Bermejo, B.
    Ibarrola-Villaba, M.
    Burgues, O.
    Ribas, G.
    Martinez, M. T.
    Lluch-Hernandez, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [28] The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer
    Andreopoulou E.
    Current Breast Cancer Reports, 2011, 3 (1) : 63 - 74
  • [29] Markers of PI3K/Akt, ER & AR pathways and Ki67 expression in relation to tamoxifen outcome in ER plus breast cancer
    Campbell, C.
    Mathew, J.
    Ellis, I.
    Finlay, P.
    Green, A.
    Bradbury, I.
    Borgquist, S.
    Elebro, K.
    Politz, O.
    Haegebarth, A.
    Gee, J. M.
    Robertson, J. F.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
    Khatpe, Aditi S.
    Adebayo, Adedeji K.
    Herodotou, Christopher A.
    Kumar, Brijesh
    Nakshatri, Harikrishna
    CANCERS, 2021, 13 (03) : 1 - 20
12345